دورية أكاديمية
Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction
| العنوان: | Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction |
|---|---|
| المؤلفون: | Pedersen, Oliver Buchhave, Hvas, Anne-Mette, Pasalic, Leonardo, Kristensen, Steen Dalby, Grove, Erik Lerkevang, Nissen, Peter H |
| المصدر: | Pedersen , O B , Hvas , A-M , Pasalic , L , Kristensen , S D , Grove , E L & Nissen , P H 2024 , ' Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction ' , Thrombosis and Haemostasis , vol. 124 , no. 3 , pp. 192-202 . https://doi.org/10.1055/s-0043-1776305Test |
| سنة النشر: | 2024 |
| المجموعة: | Aarhus University: Research |
| مصطلحات موضوعية: | microRNAs, myocardial infarction, platelet function tests, platelet maturity, platelets, Platelet Aggregation, MicroRNAs/genetics, Platelet Aggregation Inhibitors/therapeutic use, ST Elevation Myocardial Infarction/diagnosis, Humans, Percutaneous Coronary Intervention |
| الوصف: | BACKGROUND: Reduced effect of antiplatelet therapy has been reported in patients with ST-segment elevation myocardial infarction (STEMI). MicroRNAs (miRs) may influence platelet function and maturity, and subsequently the effect of antiplatelet therapy. OBJECTIVES: We aimed to explore the association between miR expression and platelet function and maturity in patients with acute STEMI and healthy individuals. METHODS: We performed an observational study of STEMI patients admitted directly to primary percutaneous coronary intervention. Patients were treated with antiplatelet therapy according to guidelines. Within 24 hours after admission, blood samples were obtained to measure: the expression of 10 candidate miRs, platelet function markers using advanced flow cytometry, platelet aggregation, serum thromboxane B2, and platelet maturity markers. Furthermore, blood samples from healthy individuals were obtained to determine the normal variation. RESULTS: In total, 61 STEMI patients and 50 healthy individuals were included. STEMI patients had higher expression of miR-21-5p, miR-26b-5p, and miR-223-3p and lower expression of miR-150-5p, miR423-5p, and miR-1180-3p than healthy individuals. In STEMI patients, the expression of miR-26b-5p showed the most consistent association with platelet function (all p-values <0.05, Spearman's rho ranging from 0.27 to 0.41), while the expression of miR-150-5p and miR-223-3p showed negative associations with platelet function. No association between miR expression and platelet maturity markers was observed. CONCLUSION: In patients with STEMI, the expression of six miRs was significantly different from healthy individuals. The expression of miR-26b-5p may affect platelet function in acute STEMI patients and potentially influence the effect of antiplatelet therapy. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://pure.au.dk/portal/en/publications/df64a6b2-624c-4372-a2ca-63d7f2f9db13Test |
| DOI: | 10.1055/s-0043-1776305 |
| الإتاحة: | https://doi.org/10.1055/s-0043-1776305Test https://pure.au.dk/portal/en/publications/df64a6b2-624c-4372-a2ca-63d7f2f9db13Test http://www.scopus.com/inward/record.url?scp=85174924539&partnerID=8YFLogxKTest |
| حقوق: | info:eu-repo/semantics/restrictedAccess |
| رقم الانضمام: | edsbas.CEE7AC61 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1055/s-0043-1776305 |
|---|